Astone, Antonio
 Distribuzione geografica
Continente #
EU - Europa 434
NA - Nord America 434
AS - Asia 97
AF - Africa 6
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 975
Nazione #
US - Stati Uniti d'America 434
DE - Germania 155
SE - Svezia 102
CN - Cina 55
UA - Ucraina 39
IT - Italia 37
IE - Irlanda 27
GB - Regno Unito 18
FR - Francia 16
SG - Singapore 14
IN - India 13
RU - Federazione Russa 11
FI - Finlandia 7
CI - Costa d'Avorio 6
IR - Iran 5
RS - Serbia 5
BE - Belgio 4
NL - Olanda 4
TR - Turchia 4
ES - Italia 3
CH - Svizzera 2
HK - Hong Kong 2
JP - Giappone 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
AU - Australia 1
BG - Bulgaria 1
CL - Cile 1
CZ - Repubblica Ceca 1
ID - Indonesia 1
PE - Perù 1
PT - Portogallo 1
SA - Arabia Saudita 1
Totale 975
Città #
Chandler 108
Dublin 26
Ashburn 21
Jacksonville 18
San Mateo 18
Boston 13
Nanjing 13
New York 13
Ann Arbor 12
Princeton 11
Singapore 11
Chicago 9
Dearborn 9
Wilmington 9
Hangzhou 8
Simi Valley 8
Houston 7
Milan 7
Moscow 7
Abidjan 6
Falls Church 6
Los Angeles 6
Marseille 6
Woodbridge 6
Belgrade 5
Bologna 5
Nanchang 5
Nürnberg 5
Rome 5
Augusta 4
Fairfield 4
Fremont 4
Izmir 4
Leawood 4
Mountain View 4
Norwalk 4
Brussels 3
Cattolica 3
Changchun 3
Kunming 3
Redwood City 3
San Diego 3
Shenyang 3
Boardman 2
Bremen 2
Busto Arsizio 2
Hefei 2
Hong Kong 2
Hyderabad 2
Jiaxing 2
Jinan 2
Lawrence 2
Legnano 2
Madrid 2
Palermo 2
San Francisco 2
Stockholm 2
Tokyo 2
University Park 2
Zhengzhou 2
Zurich 2
Antwerp 1
Beijing 1
Cambridge 1
Charleston 1
Clearwater 1
Cormeilles-en-Parisis 1
Costa Mesa 1
Edinburgh 1
Fiesole 1
Forest City 1
Fort Worth 1
Fuzhou 1
Guangzhou 1
Haikou 1
Hebei 1
Hounslow 1
Kish 1
Lancaster 1
Lima 1
Lisbon 1
Miami 1
Monmouth Junction 1
Munich 1
Ningbo 1
Pantigliate 1
Paris 1
Phoenix 1
Pune 1
Redmond 1
Riyadh 1
Santiago 1
Seattle 1
Shaoxing 1
Sofia 1
Sydney 1
Tehran 1
Tettnang 1
Tianjin 1
Valencia 1
Totale 507
Nome #
Association of IL-8 and eNOS polymorphisms with clinical outcomes in bevacizumab-treated breast cancer patients: an exploratory analysis 142
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases 121
AMAROS Study: Overall Survival in Breast Cancer Subtypes 103
Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection 96
The immune response to tumors as a tool toward immunotherapy 85
Advanced colon cancer: staging and prognosis by CEA test 79
Gas in portal circulation and pneumatosis cystoides intestinalis during chemotherapy for advanced rectal cancer 72
ERCC1 Induction after Oxaliplatin Exposure May Depend on KRAS Mutational Status in Colorectal Cancer Cell Line: In Vitro Veritas 65
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 50
Cdk4/6 inhibitor treatments in patients with hormone receptor positive, her2 negative advanced breast cancer: Potential molecular mechanisms, clinical implications and future perspectives 50
A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer 45
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting 41
Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab 31
Validation of the Meet-URO score in patients with metastatic renal cell carcinoma receiving first-line nivolumab and ipilimumab in the Italian Expanded Access Program 16
Totale 996
Categoria #
all - tutte 3.915
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.915


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020109 17 9 2 7 5 8 17 4 7 8 17 8
2020/2021100 2 8 2 9 8 5 16 2 17 8 22 1
2021/2022134 8 6 1 16 9 6 4 19 5 8 21 31
2022/2023309 29 51 16 44 19 31 15 23 44 7 19 11
2023/2024114 7 41 2 1 10 11 5 2 6 7 9 13
2024/20256 6 0 0 0 0 0 0 0 0 0 0 0
Totale 996